ArticleDisease models & mechanisms2025

Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition.

Stephanie Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.